2024 EADV Congress research shows stress can cause psoriasis relapses, while aprepitant may prevent them in 80% of cases.

Research presented at EADV Congress 2024 reveals that perceived stress can trigger psoriasis relapses. The study, using human skin xenografts on mice, found that sonic stress caused psoriatic lesions to reappear within 14 days, linked to increased immune activation and inflammation. Notably, the FDA-approved drug aprepitant effectively prevented relapses in 80% of cases. This highlights stress's role in psoriasis and suggests new treatment avenues.

September 26, 2024
6 Articles

Further Reading